Glossary entry (derived from question below)
English term or phrase:
Abagovomab
Greek translation:
abagovomab
Added to glossary by
Assimina Vavoula
Aug 31, 2010 13:08
13 yrs ago
English term
Greece
LEGAL, EU, CORPORATE TRANSLATIONS
Native in: Greek 
Works in: French to Greek, Greek to French, English to Greek, and 3 more.
Abagovomab
English to Greek
Other
Medical: Pharmaceuticals
Research
In the plenary session Dr. Cecilia Simonelli from Menarini Research gave a speech entitled: “Abagovomab and the Phase III Mimosa Study: A successful collaboration between Mediterranean Countries” which attracted considerable consensus from the audience of delegates.
Proposed translations
(Greek)
| 3 | abagovomab |
Kyriacos Georghiou
|
Change log
Sep 6, 2010 14:50: Assimina Vavoula changed "Edited KOG entry" from "<a href="/profile/76120">Assimina Vavoula's</a> old entry - "Abagovomab"" to ""abagovomab""
Sep 6, 2010 14:50: Assimina Vavoula changed "Edited KOG entry" from "<a href="/profile/76120">Assimina Vavoula's</a> old entry - "Abagovomab"" to ""abagovomab""
Proposed translations
33 mins
Kyriacos Georghiou
Cyprus
Cyprus
Native in English
&
Greek
Works in field
Cyprus
Validated translations MAPI Institute
Native in: English 
, Greek
Works in: English to Greek, Greek to English
Related KudoZ points
:
16
Selected
abagovomab
WHAT IS THE MIMOSA TRIAL?
MIMOSA is a demanding multinational trial started in December 2006 with a 9 years of duration. About 900 patients with advanced ovarian cancer who have had an optimal response to the initial treatment (surgery + chemotherapy) have been included in the study with the aim to test the efficacy and safety of the vaccination with Abagovomab for the prevention or the delay of disease’s recurrences. The first results will be available at the end of 2010.
WHAT IS ABAGOVOMAB?
Abagovomab is an antibody to be used as a therapeutic vaccine for the prevention of recurrences of ovarian cancer.
MIMOSA is a demanding multinational trial started in December 2006 with a 9 years of duration. About 900 patients with advanced ovarian cancer who have had an optimal response to the initial treatment (surgery + chemotherapy) have been included in the study with the aim to test the efficacy and safety of the vaccination with Abagovomab for the prevention or the delay of disease’s recurrences. The first results will be available at the end of 2010.
WHAT IS ABAGOVOMAB?
Abagovomab is an antibody to be used as a therapeutic vaccine for the prevention of recurrences of ovarian cancer.
4 KudoZ points awarded for this answer.
Comment: "Εντάξει.... "
Reference comments
1 hr
Reference:
Μ. ΠΙΤΣΙΛΙΔΗΣ Α.Ε.: Θεραπεία συντήρησης για τον καρκίνο ωοθηκών
- [ Translate this page ]
Ένα νέο αντι-ιδιοτυπικό αντίσωμα έναντι του CA 125 (abagovomab) βρίσκεται σήμερα υπό .... Phase I study of abagovomab in patients with epithelial ovarian, ...
www.pitsilidis.gr/magazine_gr.asp?category=15&id=900 - Cached
- [ Translate this page ]
Ένα νέο αντι-ιδιοτυπικό αντίσωμα έναντι του CA 125 (abagovomab) βρίσκεται σήμερα υπό .... Phase I study of abagovomab in patients with epithelial ovarian, ...
www.pitsilidis.gr/magazine_gr.asp?category=15&id=900 - Cached
Something went wrong...